Ann: Ethics Approval & Expedited Pathway for Phase 3 OA Trial, page-180

so true..fact is whether rightly or wrongly cyp's MC is around $76M whilst msb's is $2.4B..have been watching, researching and reading both msb and cyp for years and decided to go with msb six months ago.....each company has their merits and both have great tech....each have had their ups and downs as biotechs do, but I believe both will succeed in time, so imo, the tit for tat school ground squabble and self justification that goes on here (and on many other spec stocks on HC) is really kind of unworthy and unproductive..i just don't see its relevance nor do i believe it does just justice in this case to cyp